Evidence map›Paper›PMID 41506802›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Malignancy Detection Rates of [

Tine N Christensen, Seppo W Langer, Danijela Dejanovic, Nicholas Gillings, Jacob Madsen, Gitte Persson, Sune H Keller, Elisabeth Albrecht-Beste, Barbara M Fischer

Abstract readClinical Trial, Phase II
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tine N ChristensenDepartment of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; tine.noehr.christensen.02@regionh.dk.
Seppo W LangerDepartment of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Danijela DejanovicDepartment of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Nicholas GillingsDepartment of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Jacob MadsenDepartment of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Gitte PerssonDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; and.
Sune H KellerDepartment of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Elisabeth Albrecht-BesteDepartment of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Barbara M FischerDepartment of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary aim of this study was to investigate the malignancy detection rate of [

Indexed as

Carcinoma, Large CellGallium RadioisotopesLung NeoplasmsPositron Emission Tomography Computed TomographySmall Cell Lung CarcinomaSomatostatinAgedAged, 80 and overFemaleHumansMaleMiddle AgedGallium-68Gallium RadioisotopesSomatostatin[177Lu]Lu-SSO110 radiopharmaceutical therapy[68Ga]Ga-SSO120 PET/CTLCNECSCLCSSTR2

Identifiers

PMID41506802
PMCPMC13041608

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.